Literature DB >> 20396853

[Assessment of the cervical cancer screening in the Family Health Strategy in Amparo, São Paulo State, Brazil].

Diama Bhadra Andrade Peixoto do Vale1, Sirlei Siani Morais, Aparecida Linhares Pimenta, Luiz Carlos Zeferino.   

Abstract

Uterine cervical cancer mortality has not been declining. The territorial distribution and registration of families in Brazil's Family Health Strategy help identify women that have performed a Pap smear or that have not had one for more than three years. This study analyzed whether cervical cancer screening in Amparo, São Paulo State, Brazil, made progress in complying with the prevailing guidelines during the seven years of experience with the Strategy. The annual examination rate remained high, with a slight trend towards greater intervals between follow-up tests. Distribution of tests tended to increase in the 40-59-year age bracket and decrease in the over-60 age group, while annual coverage tended to decrease. The proportions of excess tests varied from 61.2% to 65.5%. Concluding, the upgrading of cervical cancer screening was slight, and did not change the opportunistic pattern of follow-up tests. Considering that community health agents can act to increase the coverage of these measures, it is essential to train them for this work.

Entities:  

Mesh:

Year:  2010        PMID: 20396853     DOI: 10.1590/s0102-311x2010000200017

Source DB:  PubMed          Journal:  Cad Saude Publica        ISSN: 0102-311X            Impact factor:   1.632


  8 in total

1.  Cervical cancer screening coverage in a high-incidence region.

Authors:  Cibelli Navarro; Allex Jardim da Fonseca; Alexander Sibajev; Camila Iasmim de Andrade Souza; Daniela Souza Araújo; Daniele Aparecida de Freitas Teles; Stéphanie Gomes Lins de Carvalho; Kyldery Wendell Moura Cavalcante; Wendell Lima Rabelo
Journal:  Rev Saude Publica       Date:  2015-02-27       Impact factor: 2.106

2.  Estimating long-term clinical effectiveness and cost-effectiveness of HPV 16/18 vaccine in China.

Authors:  Qian Zhang; Yi-Jun Liu; Shang-Ying Hu; Fang-Hui Zhao
Journal:  BMC Cancer       Date:  2016-11-04       Impact factor: 4.430

3.  Effect of vaccination age on cost-effectiveness of human papillomavirus vaccination against cervical cancer in China.

Authors:  Yi-Jun Liu; Qian Zhang; Shang-Ying Hu; Fang-Hui Zhao
Journal:  BMC Cancer       Date:  2016-02-26       Impact factor: 4.430

4.  Estimating the public health impact of a national guideline on cervical cancer screening: an audit study of a program in Campinas, Brazil.

Authors:  Diama Bhadra Vale; Talita Lourenço Menin; Joana Froes Bragança; Julio Cesar Teixeira; Lucas Almeida Cavalcante; Luiz Carlos Zeferino
Journal:  BMC Public Health       Date:  2019-11-08       Impact factor: 3.295

Review 5.  Systematic review of the cost-effectiveness of the vaccination against HPV in Brazil.

Authors:  Allex Jardim Fonseca; Luiz Carlos de Lima Ferreira
Journal:  Hum Vaccin Immunother       Date:  2014       Impact factor: 3.452

6.  Historical Analysis of the Brazilian Cervical Cancer Screening Program from 2006 to 2013: A Time for Reflection.

Authors:  Ricardo Filipe Alves Costa; Adhemar Longatto-Filho; Céline Pinheiro; Luiz Carlos Zeferino; José Humberto Fregnani
Journal:  PLoS One       Date:  2015-09-24       Impact factor: 3.240

7.  Integrality in cervical cancer care: evaluation of access.

Authors:  Keila Brito-Silva; Adriana Falangola Benjamin Bezerra; Lucieli Dias Pedreschi Chaves; Oswaldo Yoshimi Tanaka
Journal:  Rev Saude Publica       Date:  2014-04       Impact factor: 2.106

8.  Trend analysis of the quality indicators for the Brazilian cervical cancer screening programme by region and state from 2006 to 2013.

Authors:  Ricardo Filipe Alves Costa; Adhemar Longatto-Filho; Fabiana de Lima Vazquez; Céline Pinheiro; Luiz Carlos Zeferino; José Humberto Tavares Guerreiro Fregnani
Journal:  BMC Cancer       Date:  2018-02-02       Impact factor: 4.430

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.